MBP and myeloid sarcoma: It will be necessary to confirm these results in larger cohorts of patients; it will be interesting to design follow-up studies on patients in the initial phases of the disease in order to verify whether MBP concentration in ODEVs will allow the precocious identification of different clinical MS phenotypes.